These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2010-023962-39 A randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy 2012-06-04 due-trials
Reported results 2010-023963-16 A Phase IIa Placebo-Controlled, Double-Blind Randomised Withdrawal Study to Evaluate the Safety and Efficacy of CNV1014802 in Patients with Trigeminal Neuralgia. Estudio de fase IIa, controlado con... 2014-02-26 due-trials
Reported results 2012-002903-16 A randomised, double-blind, crossover study to compare the efficacy and safety of CNV2197944 75 mg tid versus placebo in patients with post-herpetic neuralgia 2014-02-06 due-trials
Reported results 2013-000407-16 A randomised three week double-blind crossover study to compare the efficacy and safety of CNV2197944 75 mg tid versus placebo in the treatment of neuropathic pain in patients with diabetic peripheral... 2014-06-30 due-trials
Reported results 2015-004775-78 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BIIB074 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy 2018-08-06 due-trials
Reported results 2015-004796-68 An Uncontrolled, Open-Label Extension Study to Evaluate the Long Term Safety, Tolerability, and Maintenance of Effect of BIIB074 (Vixotrigine) in Subjects With Neuropathic Pain From Lumbosacral Radicu... 2019-02-08 due-trials

Related organisations

Over time organisations can merge, or split.

We think Convergence Pharmaceuticals Ltd is now effectively part of Biogen.